The two startups will utilise the capital for business growth including strategic expansion, product development, R&D and technology investments
The recipient is a 57-year-old woman who was suffering from severe biventricular heart failure and had undergone cardiac surgery several years ago
The purchaser is a part of the portfolio companies of PE firm True North. The said transaction is not a related party transaction.
It becomes the first ophthalmology biosimilar to gain FDA approval in the United States
MeMed BV is a first-of-its-kind test that decodes the immune response to accurately distinguish between bacterial or viral infections within minutes
Cephalosporin is a bactericidal, broad-spectrum, and P-lactam antibiotic originally derived from the fungus Acremonium, which is used to treat bacterial infections such as pneumonia, skin infections, ear infection, strep throat, staph infections, tonsillitis, bronchitis among others
Eka Care will provide a six-month complimentary trial period to all members who register before December 31, 2021
It is the first-ever fully remote end-to-end Remote Patient Monitoring (RPM) service to include cardiac arrhythmia analysis in a single, intuitive platform
The country’s vaccine production has more than doubled since April and is set to touch 300 million doses next month
If approved, Gavreto will be the first and only targeted treatment approved by the EMA that includes first-line treatment of people with RET fusion-positive advanced NSCLC
Subscribe To Our Newsletter & Stay Updated
